David R. Brennan
CIK: 0001609305
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (16.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)3 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INSM
INSMED Inc
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 9, 2026INSM
INSMED Inc
Sale(S)Direct25K shares at avg. $124.00$3.1M - May 13, 2026INSM
INSMED Inc
Award(A)Direct3.3K shares- - Feb 23, 2026INSM
INSMED Inc
Gift(G)Direct6K shares- - Nov 6, 2025INSM
INSMED Inc
Gift(G)Direct60K shares- - Nov 6, 2025INSM
INSMED Inc
Gift(G)Indirect60K shares- - May 15, 2025INSM
INSMED Inc
Award(A)Direct5.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 9, 2026 | INSM INSMED Inc | Sale(S) | 25,000 | $124.00 | $3,100,000 | Direct |
| May 13, 2026 | INSM INSMED Inc | Award(A) | 3,305 | - | $0 | Direct |
| Feb 23, 2026 | INSM INSMED Inc | Gift(G) | 6,000 | - | $0 | Direct |
| Nov 6, 2025 | INSM INSMED Inc | Gift(G) | 60,000 | - | - | Direct |
| Nov 6, 2025 | INSM INSMED Inc | Gift(G) | 60,000 | - | - | Indirect |
| May 15, 2025 | INSM INSMED Inc | Award(A) | 5,058 | - | - | Direct |
1-6 of 6 transactions
About Brennan David R
Brennan David R (SEC CIK 0001609305) files insider reports with the SEC as Director of INSMED Inc (INSM).
Signal8 holds 5 ownership filings by Brennan David R, all Form 4s, filed between May 19, 2025 and Sep 11, 2026. Those filings report 6 transactions, from May 15, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Brennan David R's filings is in BRIDGEWATER, NJ.
Recent filings by Brennan David R
Other insiders filing for INSMED Inc (INSM)
- Koppikar Utpal, Director
- Hudson Paul, Director
- SHAROKY MELVIN MD, Director
- Adsett Roger, Chief Operating Officer
- Flammer Martina M.D., Chief Medical Officer
- Lewis William, Chair and CEO